Reuters logo
BRIEF-U.S. Court issues adverse decision concerning Allergan's Restasis
2017年10月16日 / 晚上6点07分 / 1 个月前

BRIEF-U.S. Court issues adverse decision concerning Allergan's Restasis

Oct 16 (Reuters) - Allergan Plc

* U.S. District Court for the Eastern District of Texas issues adverse trial decision concerning Restasis (cyclosporine ophthalmic emulsion) 0.05% patents

* Says ‍company will appeal court’s ruling regarding Restasis​

* Says ‍“we are disappointed” by Federal District Court’s decision on Restasis patents​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below